Zotatifin

Generic Name: Zotatifin

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₈H_₂₉N_₃O_₅

CAS Number: 2098191-53-6

Unique Ingredient Identifier: 2EWN8Z05CN

Background: Zotatifin is under investigation in clinical trial NCT04092673 (Study of Eft226 in Subjects With Selected Advanced Solid Tumor Malignancies).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer

Tyra Biosciences appoints Dr. Doug Warner as Chief Medical Officer, overseeing clinical portfolio and joining executive management team. Dr. Warner brings 20+ years of clinical development experience in oncology and skeletal diseases.

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy